38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	Is a	General adjectival modifier	false	Inferred relationship	Some
un	Is a	nombre	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Sulfacetamide sodium 100 mg/g eye ointment	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Sulfacetamide sodium 100 mg/g eye ointment	Count of base of active ingredient	False	un	Inferred relationship	Some
Estradiol 2.5 microgram/hour prolonged-release transdermal patch	Count of base of active ingredient	False	un	Inferred relationship	Some
Estradiol 2.5 microgram/hour prolonged-release transdermal patch	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Triamcinolone diacetate 25 mg/mL suspension for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Triamcinolone diacetate 25 mg/mL suspension for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely promazine 10 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely promazine 10 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely pyridostigmine bromide 12 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely pyridostigmine bromide 12 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely pentamidine isethionate 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely pentamidine isethionate 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely methylprednisolone 125 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely methylprednisolone 125 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	3
Bupivacaine hydrochloride 1.05 mg/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Bupivacaine hydrochloride 1.05 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	3
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely methacholine 25 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely methacholine 25 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely thioridazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely thioridazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Esmolol hydrochloride 250 mg/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Esmolol hydrochloride 250 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength numerator value	False	un	Inferred relationship	Some	1
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ketotifen 200 microgram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ketotifen 200 microgram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Salbutamol (as salbutamol sulfate) 2.5 mg/actuation solution for inhalation	Count of base of active ingredient	False	un	Inferred relationship	Some
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution	Has concentration strength numerator value	False	un	Inferred relationship	Some	1
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Sulfafurazole 100 mg/mL oral suspension	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Sulfafurazole 100 mg/mL oral suspension	Count of base of active ingredient	False	un	Inferred relationship	Some
Ergometrine 200 microgram/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Ergometrine 200 microgram/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Betamethasone (as betamethasone dipropionate) 5 mg/g cutaneous ointment	Count of base of active ingredient	False	un	Inferred relationship	Some
Betamethasone (as betamethasone dipropionate) 5 mg/g cutaneous ointment	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely oxacillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely oxacillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Hydralazine hydrochloride 20 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Hydralazine hydrochloride 20 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Sulfacetamide sodium 200 mg/mL eye solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Sulfacetamide sodium 200 mg/mL eye solution	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely mesoridazine 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely mesoridazine 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely acetic acid 20 milligram/1 milliliter conventional release ear solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely acetic acid 20 milligram/1 milliliter conventional release ear solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Eflornithine (as eflornithine hydrochloride) 139 mg/mL cutaneous cream	Count of base of active ingredient	False	un	Inferred relationship	Some
Eflornithine (as eflornithine hydrochloride) 139 mg/mL cutaneous cream	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Estradiol 3.13 microgram/hour prolonged-release transdermal patch	Count of base of active ingredient	False	un	Inferred relationship	Some
Estradiol 3.13 microgram/hour prolonged-release transdermal patch	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Sulfacetamide sodium 60 mg/g eye ointment	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Sulfacetamide sodium 60 mg/g eye ointment	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Acetic acid 9 mg/g and oxyquinoline (as oxyquinoline sulfate) 250 microgram/g vaginal gel	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Acetic acid 9 mg/g and oxyquinoline (as oxyquinoline sulfate) 250 microgram/g vaginal gel	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Prochlorperazine 1 mg/mL oral solution	Has concentration strength numerator value	False	un	Inferred relationship	Some	1
Prochlorperazine 1 mg/mL oral solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Prochlorperazine 1 mg/mL oral solution	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Trimethobenzamide hydrochloride 100 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1

Start Previous Page 189 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module